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Abstract
Asthma is a common disease causing cough, wheezing and shortness of breath. It has
been shown that the lung microbiota in asthma patients is different from the lung microbiota
in healthy controls suggesting that a connection between asthma and the lung microbiome
exists. Individuals with asthma who are also tobacco smokers experience more severe
asthma symptoms and smoking cessation is associated with improved asthma control. In
the present study we investigated if smoking cessation in asthma patients is associated
with a change in the bacterial community in the lungs, examined using induced sputum. We
found that while tobacco smokers with asthma have a greater bacterial diversity in the
induced sputum compared to non-smoking healthy controls, smoking cessation does not
lead to a change in the microbial diversity.
Introduction
Traditionally the lungs have been considered a sterile environment. However, with the advent
of culture independent techniques to study bacterial populations it has been shown that the
lungs harbor a specific bacterial community [1]. Several studies have used culture independent
techniques to characterize the bacterial community in the lungs of different individuals includ-
ing tobacco smokers, asthma patients, patients with chronic obstructive pulmonary disease
(COPD) and healthy controls [2–5].
For individuals with asthma it has been shown that the bacterial community in the lungs is
different from the community in healthy controls [2,6–8]. Specifically, it has been found that
the bacterial diversity in the lungs of asthma patients is greater than the bacterial diversity in
the lungs of healthy controls and that the diversity correlates with bronchial hyper responsive-
ness [6,8].
Studies of the lung microbiota in tobacco smoking individuals who are otherwise healthy
indicate that smoking is not associated with changes in the bacterial composition compared to
individuals who are non-smokers [4]. In contrast, studies of the oral microbiome of tobacco
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smokers found that smoking is associated with changes in the oral microbiome compared to
non-smokers [4,5]. However, the extent to which tobacco smoking is associated with changes
in the microbiome in individuals with an underlying pulmonary disease is not well known. In
asthma patients, tobacco smoking is associated with increased asthma symptom severity as
well as increased risk of asthma-exacerbations and death [9,10]. Furthermore, tobacco smokers
with asthma have a significantly increased risk of pneumonia compared to healthy controls
[11]. Despite this, cigarette smoking is as common in people with asthma as in healthy individ-
uals [9].
We have recently shown that cigarette smoking asthma patients who quit smoking experi-
ence an overall increase in asthma control as well as reduced airway hyper responsiveness
[12,13]. Whether the smoking cessation is associated with changes in the bacterial communi-
ties in the lungs is not known. The aim of the present study was to use culture independent
techniques to analyze the bacterial community in sputum samples collected longitudinally
from cigarette smoking asthma patients who attempt smoking cessation. Specifically, we tested
the hypothesis that smoking cessation is associated with changes in bacterial diversity.
Material and Methods
Study group
The 44 asthma patients enrolled in this study were part of a randomized clinical trial on the
effect of varenicline versus placebo on cigarette smoking cessation in individuals with asthma
[13]. The study design of the randomized trial, including detailed inclusion and exclusion crite-
ria, have been described previously [12]. In summary, 52 cigarette smoking asthma patients
who had not, within the last 3 months, experienced lower respiratory tract infections or
received treatment with inhaled or systemic corticosteroids were randomized 1:1 to receive
either varenicline or placebo for 12 weeks. Induced sputum samples for microbiological analy-
sis were collected at two time points, week 0 and week 12. Among the 52 randomized patients,
8 patients were excluded from the present study since they either dropped out or did not com-
plete the collection of induced sputum at both week 0 and week 12. The cigarette smoking status
of the patients was evaluated through interview and CO breath test at week 0, week 6 and week
12. In addition to the patient samples, baseline control samples were also collected from a group
of 20 non-smoking, non-asthmatic healthy controls, recruited through advertisement. The study
was approved by The Copenhagen County Ethical Committee (www.regionh.dk/vek, ref. H-2-
2010-140) and all asthma patients and control subjects provided written, informed consent. The
randomized trial was registered at clinicaltrial.gov (NTC: NCT02233231) under the identifier:
"Young smoking asthmatics".
Sputum sample collection
Prior to collecting the induced sputum sample, participants washed their mouth with water to
reduce oral contamination. For each patient, 1–2 ml induced sputum sample was collected and
transferred directly to a sterile 15 ml tube containing 4 ml lysogeny broth (LB) medium with
27% glycerol, as we generally experience that LB preserves cultivability. The tubes were kept on
ice and immediately frozen at -20°C and transferred to -80°C. Further details on the collection
of induced sputum in this study have been published previously [13,14].
DNA extraction
The samples were thawed at room temperature and 5 ml 0.2% dithiothreitol (DTT) solution
was mixed with the sample and incubated for 10–15 minutes at room temperature to dissolve
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viscous sample parts. Next, the tubes were centrifuged at 7500 g for 5 minutes and the superna-
tant was removed. The pellet was heat inactivated for 5 minutes at 95°C in order to kill poten-
tial pathogens. The pellet was dissolved in 500 μl bead solution from the PowerLyzer™
PowerSoil1 DNA Isolation Kit (MOBIO) and DNA was extracted according to the manufac-
ture’s protocol using the Fast Prep (MPBIO) homogenizer at speed 6 for 40 seconds. The DNA
was eluted in 50 μl elution buffer and stored at -20°C.
16S sequencing
For each of the 88 patient samples and the 20 control samples DNA was extracted and analyzed
by 16S rRNA gene amplicon sequencing using the 454 FLX platform (Roche). All 16S libraries
were constructed by amplifying the V3-V4 region of the 16S rrna gene using the 341F primer
CCTAYGGGRBGCASCAG and the 806R primer GGACTACNNGGGTATCTAAT [15]. PCR
was performed using the AccuPrime PCR mixture (Invitrogen) with 5 μl template in a total
volume of 25 μl using the following cycling conditions: 94°C for 2 min followed by 30 cycles of
94°C for 20 sec, 56°C for 30 sec, 68°C for 40 sec and final extension at 68°C for 5 min. After
PCR the 16S V3-V4 band was gel extracted using the Montage gel extraction kit (Millipore).
For PCR reactions that did not result in a visible band (8 at week 0, 4 at week 12 and 7 controls)
the template DNA concentrations were measured using a Qubit (Invitrogen), in all cases the
DNA concentration was less than 1 ng/μl. These samples were successfully amplified in a new
PCR attempt using 10 μl template and 35 cycles. In parallel with all 16S rRNA gene amplifica-
tions control reactions with no template were run, which gave no PCR product. Next all sam-
ples were barcoded in a second 15 cycles PCR reaction using 2 μl template from the first PCR
reaction. The DNA concentration of the barcoded samples was measured with Qubit and the
samples were pooled to equal quantities and sequenced using the 454 FLX platform (Roche).
Data analysis
Quality filtering, read trimming and OTU clustering was done according to the UPARSE pipe-
line [16]. Briefly, reads were trimmed to 400 bp and singletons or reads with expected error
greater than 0.5 were filtered out. OTUs were defined using an identity cut-off of 97% as this
generally approximates the difference in 16S sequences between bacterial species [17]. The
OTU clusters were filtered for chimeras using the Gold database [13]. Taxonomy was assigned
using the rdp classifier in QIIME and greengenes 13_8 reference database (greengenes.lbl.gov)
trimmed to sequences with complete taxonomic path [18,19]. Subsequent data analysis was
performed in R using the phyloseq package to calculate diversity measures and in Stata (Stata-
Corp LP) version 13.1 to perform statistical analysis [20].
For comparisons between asthma patients and controls and for comparisons at baseline
between cigarette quitting and non-quitting asthma patients, unpaired t-test and Mann-Whit-
ney U-test was applied for continuous variables with parametric and non-parametric distribu-
tions respectively. For categorical variables, Pearson's chi-squared test was applied. When
comparing differences in change from week 0 to week 12 between quitters and non-quitters or
between the varenicline and the placebo group, unpaired t-test and Mann-Whitney U-test
using the paired differences (change from week 0 to week 12) was applied for paired differences
with parametric and non-parametric distributions respectively. In the comparison of the quit-
ters at week 0 to week 12, a paired t-test and a Wilcoxon Signed-Rank Test was used for contin-
uous variables with parametric and non-parametric distributions respectively. The trimmed
greengenes database includes 277 different bacterial families. Since our analysis of differences
in abundance of specific families was exploratory and not driven by pre-specified hypotheses,
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all analysis regarding specific families were adjusted for 277 multiple comparisons using the
Bonferroni method.
Results
Baseline profile
Of the 44 included asthma patients, 25 had quit cigarette smoking at week 12 while 19 had not.
Of the 25 who quit cigarette smoking 24 had already stopped at week 6, highlighting that smok-
ing cessation for the most part occurred early in the intervention. Detailed baseline characteris-
tics for the 44 patients according to smoking status at week 12 has been published previously
[12] and are summarized along with baseline characteristics for the 20 healthy control subjects
in Table 1. There were no differences at baseline with respect to age, sex, spirometric variables
or cumulative smoking in pack-years between the patients who quit smoking and those who
did not (Table 1).
In total, 88 16S rRNA gene amplicons from the asthma patients and 20 amplicons from the
healthy controls were sequenced. On average each amplicon contained 7844 sequences (S1
Fig). Clustering of these sequences at 97% identity resulted in a total of 476 different opera-
tional taxonomic units (OTUs) with each sample on average containing 120 OTUs (sd = 25)
(S2 Fig). Rarefaction curve analysis showed that the majority of the OTUs in each sample were
captured, indicating that the sequencing depth was sufficient to uncover most of the diversity
in the sample (S3 Fig).
At week 0 the samples from the asthma patients contained a total of 378 different OTUs
with each sample on average containing 123 OTUs (sd = 25) (S2 Fig). Taxonomy could be
assigned to the level of genus or lower to 157 of the 378 OTUs (42%) and to family or lower to
267 (71%) of the OTUs. As the taxonomic resolution of the relatively short (400 bp) 16S rRNA
gene sequences is limited [14] the taxonomic profiles of the samples are presented at the family
level. The ten most abundant families, measured as the mean of the relative abundance in each
sample, were Prevotellaceae (17%), Fusobacteriaceae (13%), Streptococcaceae (9%), Pasteurel-
laceae (8%), Porphyromonadaceae (7%), Leptotrichiaceae (7%), Veillonellaceae (6%), Neisser-
iaceae (4%), Actinomycetaceae (3%) and Campylobacteraceae (2%) (Fig 1). These families
have all been reported in previous studies of the lung microbiome and are also common mem-
bers of the oral microbiome [3,4,21]. As the difference between the lung and the oral micro-
biome to a large extend is abundance driven, as opposed to species driven, it is challenging to
filter-out the oral flora from the lung microbiome [4,21].
Comparisons of the bacterial diversity in the week 0 patient samples to the control samples
showed that both the number of OTUs and the Shannon index were significantly higher in the
Table 1. Baseline characteristics for controls and asthma patients according to cigarette smoking status at week 12.
Parameters Controls Quitters Non-quitters P*
Individuals, n 20 25 19 -
Age, years 25 ± 3 32 ± 6 32 ± 6 0.84
Male sex, % 10 (50%) 15 (60%) 13 (68%) 0.57
FEV1, % of predicted 101 ± 9 84 ± 18 83 ± 16 0.86
FVC, % of predicted 104 ± 11 97 ± 14 96 ± 12 0.81
FEV1/FVC, % 83 ± 7 72 ± 10 73 ± 10 0.89
Cumulative smoking, pack-years 0 16 ± 5 16 ± 4 0.91
Mean ± SD are shown for continuous variables while number (%) is shown for categorical variables.
*P-value for cigarette quitters versus non-quitters using unpaired t-test and Pearson's chi-squared test for continuous and categorical variables respectively.
doi:10.1371/journal.pone.0158622.t001
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patient samples relative to the healthy controls (P = 2  10−7 and P = 6  10−6, respectively,
unpaired t-test) (Fig 2A and 2B). While the number of OTUs is a simple unweighted measure
of diversity the Shannon index takes into account the relative abundances of each OTU in a
sample [22].
To further explore the difference between the controls and the patient group we identified
the ten bacterial families with the largest absolute difference in mean abundance between the
Fig 1. Most abundant bacterial families at week 0. The distribution of the ten most abundant families in the
week 0 asthma patient samples. For each sample (n = 44) the percent of the reads belonging to the specified
family is shown. The vertical crossbar marks the mean of the distribution.
doi:10.1371/journal.pone.0158622.g001
Fig 2. Diversity at week 0. A) The distribution of unique OTUs in the asthma patients and the healthy
controls. The solid crossbars mark the mean of each distribution. The samples from the asthma patients
contain significantly more unique OTUs compared to samples from the healthy controls (unpaired t-test). B)
The Shannon diversity index in samples from the asthma patients and the healthy controls. The solid
crossbars mark the mean of each distribution. Samples from the asthma patients contain a significantly
higher bacterial diversity than samples from the healthy controls (unpaired t-test).
doi:10.1371/journal.pone.0158622.g002
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two groups (Fig 3). Two of these families, Streptococcaceae (P = 2  10−6, Mann-Whitney U-test)
and Spirochaetaceae (P = 1  10−5) were significantly more abundant in the asthma patients com-
pared to the controls after correction for 277 multiple comparisons using the Bonferroni-method
(required P-value< 1.81  10−4 = 0.05 / 277 unique OTUs in the database). However, as these
families contain several species commonly found in the oral and lung flora, including opportu-
nistic pathogens, it is difficult to comment on the clinical implications of this finding.
Changes associated with smoking cessation
The longitudinal design of our study allowed us to compare changes in the bacterial communi-
ties in the lungs within the same patients before and after cigarette smoking cessation. This
helped eliminate inter-patient variation, which could otherwise mask the changes. At week 12,
25 patients had quit cigarette smoking while 19 were still smoking (Table 1). When comparing
quitters and non-quitters there was no significant difference in the mean change (i.e. from
week 0 to week 12) in the number of unique OTUs (P = 0.43, unpaired t-test of the paired dif-
ferences) or the Shannon index (P = 0.35, unpaired t-test of the paired differences) (Fig 4A and
4B). Similarly, when comparing the change in the number of OTUs and the Shannon index
from week 0 to week 12 according to randomization (i.e. varenicline vs. placebo) we found no
significant differences between the two groups (P = 0.45 and P = 0.61, respectively, unpaired t-
test of the paired differences S4 Fig).
As all patients attempted smoking cessation we cannot rule out that the non-quitter group
displayed reduced smoking frequency potentially masking the effect of smoking cessation on
the diversity in the microbiome. To reduce this impact we investigated if there was any change
Fig 3. Most different bacterial families at week 0. The ten families with the biggest absolute difference in
mean abundance in samples from asthma patients relative to samples from healthy controls at week 0. The
crossbar marks the mean of each distribution. NS P-value not significant at the 0.05 confidence level after
correction for 277 multiple comparisons using the Bonferroni-method (Mann-Whitney U test, required P-
value < 1.81 * 10−4 = 0.05 / 277).
doi:10.1371/journal.pone.0158622.g003
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in the bacterial diversity within the quitter group alone. We found no significant change in the
number of OTUs or the Shannon index from week 0 to week 12 (P = 0.08 and P = 0.38, respec-
tively, paired t-test)(S5 Fig). While this comparison cannot account for biological variation or
non-intervention effects, it does highlight that when looking at the quitters alone, there is no
obvious association between quitting cigarette smoking and the microbiome diversity. This
suggests, that although cigarette smoking asthma patients who quit smoking experience
improved asthma control and reduced airway hyper responsiveness this is not, after a ciga-
rette-free period of at least 6 weeks, accompanied by a change in the bacterial diversity of the
lung microbiome.
To explore if specific bacterial families were affected by smoking cessation we identified the
five families with the largest mean change in the quitter group. For these families we compared
the change (i.e. from week 0 to week 12) in the quitter group to the change in the non-quitter
group (Mann-Whitney U-test of the within-patient change in the quitter group compared to
the within-patient change in the non-quitter group) (Fig 5). For each family, except Neisseria-
ceae and Porphyromonadaceae, the change in abundance from week 0 to week 12 was in the
same direction for both the quitter and the non-quitter group (Fig 5). As all samples were pro-
cessed in parallel this uniform shift is not likely to be caused by differences in laboratory proce-
dures. None of the changes in family abundance were significantly different between the
quitter group and the non-quitter group (Fig 5). This indicates that within the investigated
timespan smoking cessation was not associated with major changes in specific bacterial fami-
lies in the sputum microbiome. To investigate if a potential reduced smoking frequency in the
non-quitter group could mask a difference in the five families, we compared the family abun-
dances at week 0 to the abundance at week 12 for the quitter group. In this comparison we
found no significant difference in any of the five families (Wilcoxon Signed-Rank Test, data
not shown).
Fig 4. Bacterial diversity at week 0 and week 12. A) The number of unique OTUs for the non-quitters and the quitters at week 0
and week 12. The solid crossbars mark the mean of each distribution. When comparing the change (i.e. from week 0 to week 12)
in the non-quitter group to the change in the quitter group no significant difference was found (P = 0.43, unpaired t-test of the
paired differences). B) The Shannon diversity index for the non-quitters and quitters at week 0 and week 12. The solid crossbars
mark the mean of each distribution. When comparing the change (i.e. from week 0 to week 12) in the non-quitter group to the
change in the quitter group no significant difference was found (P = 0.35, unpaired t-test of paired differences).
doi:10.1371/journal.pone.0158622.g004
Cigarette Smoking Asthma Patients and the Induced SputumMicrobiome
PLOSONE | DOI:10.1371/journal.pone.0158622 July 8, 2016 7 / 11
Discussion
We have recently shown that cigarette smoking cessation is associated with improvements in
asthma control in cigarette smoking asthma patients [12]. In the present study we investigated
if smoking cessation was also associated with changes in the bacterial diversity of the sputum
microbiome. We investigated the microbiome of induced sputum samples from 44 cigarette
smoking asthma patients before and after attempting smoking cessation. Due to the
Fig 5. Families that differedmost after attempting smoking cessation. The five families, within the group
of patients that quit cigarette smoking, with the largest mean change (i.e. from week 0 to week 12) in relative
abundance. When comparing the change in abundance (i.e. from week 0 to week 12) in the quitter group to
the change in the non-quitter group there was no significant differences (Mann-Whitney U-test of the within-
patient change in the quitter group compared to the within-patient change in the non-quitter group).
doi:10.1371/journal.pone.0158622.g005
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longitudinal sampling design we could quantify the changes in the microbiome within each
participant reducing inter-subject variations.
We found no significant difference in the changes in the bacterial communities between
asthma patients who quit cigarette smoking and those who did not. However, as both groups
attempted smoking cessation we cannot rule out that the patients in the non-quitter group
changed their smoking habits in terms of the amount of daily use or intermittent quitting. Con-
sequently, we investigated the change within the group of patients that successfully quit ciga-
rette smoking and found no association between smoking cessation and the bacterial
community. This suggests that there is no strong association between smoking cessation and
changes in the sputum microbiome. Yet, it is still possible that a larger sample size or a longer
follow-up period would have detected a change.
We did find that bacterial diversity, measured both by the number of unique OTUs and the
Shannon index, was significantly higher in the cigarette smoking asthma patients compared to
the healthy non-smoking controls. This corroborates previous findings showing that the bacte-
rial diversity in the lungs of asthma patients is more diverse than that of healthy controls [6,8].
However, as the control-group consisted of non-smokers without asthma we cannot directly
conclude on the association between asthma and the sputum microbiome.
In contrast to our and others findings [6,8], Park et al. have found that the bacterial diversity
in oropharyngeal samples from asthma patients is lower than that of healthy controls [7]. How-
ever, as samples were collected from different sites, it is difficult to directly compare their find-
ings with the results presented here.
At the bacterial family level we found two families to be significantly enriched in the sputum
of cigarette smoking asthma patients compared to healthy controls; Streptococcaceae and Spir-
ochaetaceae. Yet, it is difficult to evaluate the clinical implications of this finding as both fami-
lies contain species commonly found in the oral cavity and upper respiratory tract.
Furthermore, as we did not specify any hypothesis with respect to changes in specific bacterial
families the analysis of the changes in bacterial families required correction for multiple
hypotheses testing, which greatly reduces statistical power. As a result, it is difficult to interpret
the non-significant findings with a low p-value in the families in Fig 3. Still, our exploratory
analysis can aid in the hypothesis development for future studies of the bacterial communities
in the lungs.
In the present study, samples were collected using induced sputum, which represents a non-
invasive alternative to bronchoalveolar lavage (BAL). Samples were transferred to a LB + glyc-
erol medium and immediately stored on ice. However, the nutrient rich medium could in the-
ory have affected the bacterial population. In order to reduce oral contamination participants
washed their mouth with water before giving the sputum sample. Yet, induced sputum samples
will suffer from oral contamination.
Studies comparing the microbiome at different sites along the aerodigestive tract find that this
body site constitutes a microbiological continuum with substantial species overlap but varying
abundances, [4,21,23]. Consequently, it is challenging to define a distinct lung microbiome and
to filter out upper airway- or oral contamination from the induced sputum 16S data.
Recently a study comparing the lung microbiome of healthy tobacco smokers and non-
smokers found no difference between the two groups [4]. Since the study was done on healthy
individuals, smoking associated changes in the lung microbiome that causes disease may be
overlooked. Accordingly, some of the increased risk and severity of pulmonary disorders in
tobacco smokers with asthma [11] could still be mediated through smoking-induced changes
in the lung microbiome. However, our results suggest that the improvements in asthma control
immediately following cigarette-smoking cessation is not directly linked with changes in the
sputum microbiome.
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